The Global Hidradenitis Suppurativa (HS) Treatment Industry is on the brink of a substantial transformation, as it is anticipated to exceed a noteworthy valuation of US$ 763.6 million in 2023 and is projected to soar to an impressive US$ 1,240.9 million by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 4.97%. The market …